Wuhan Qirui Technology Development Co., Ltd. is a national high-tech enterprise that integrates research and development, production, and sales. The company was founded in 2001 and currently has over 1600 employees, with annual sales exceeding 2 billion yuan. It has 8 member companies, mainly located in Wuhan, Shanghai, Ezhou, Huanggang, and Jining, Shandong, including two innovative drug research and development centers, one pharmaceutical raw material research and development production base, one pilot production and transformation base for biological and fermented products, one formulation research and development and production base, one chemical production base, one consumer goods production base, and one marketing center.

The company has completed multiple innovative research projects with global leading level in the fields of cardiovascular and cerebrovascular diseases, autoimmune diseases, respiratory system diseases, digestive diseases, and fungal infections in accordance with international standards. Relying on its own research and development strength, it has undertaken more than 50 projects including the National "Major New Drug Creation" Science and Technology Major Special Project, the Ministry of Science and Technology High tech Industrialization Special Project, the National Development and Reform Commission Key Industry Revitalization and Technological Transformation Project, the Hubei Province Major Technical Innovation Special Project, and the Wuhan City Key R&D Plan. The company has been successively awarded numerous platforms such as the National Local Joint Engineering Research Center, National Postdoctoral Research Workstation, Hubei Cardiovascular Drug Engineering Technology Research Center, and Provincial Enterprise Technology Center, and has been honored with titles such as National Technology Innovation Demonstration Enterprise, Hubei Province Specialized, Refined, Unique and New Small Giant Person, and Hubei Province Invisible Champion Demonstration Enterprise.

Based on the full process information processing of research and development and production, the company has built a high difficulty technology platform with "intelligence" and "system" as the core, relying on big data. It is transforming from a traditional high-tech enterprise integrating science, industry, and trade to an international high-tech research-oriented enterprise integrating global resources and paying more attention to intellectual property development and operation. The company will adhere to the core values of "quality" and "responsibility", build Qirui into a representative of progressiveness in the field of life and health, and continue to provide high-quality professional products and services for human health.